Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.85 - $3.73 $119,700 - $156,660
-42,000 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$3.24 - $5.18 $90,720 - $145,040
-28,000 Reduced 40.0%
42,000 $2,000
Q3 2021

Nov 12, 2021

BUY
$3.94 - $5.84 $275,800 - $408,800
70,000 New
70,000 $37,000
Q1 2021

May 04, 2021

SELL
$5.03 - $8.8 $163,475 - $286,000
-32,500 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$4.04 - $5.31 $22,220 - $29,204
5,500 Added 20.37%
32,500 $10,000
Q3 2020

Nov 03, 2020

BUY
$3.64 - $7.76 $16,380 - $34,920
4,500 Added 20.0%
27,000 $6,000
Q2 2020

Aug 13, 2020

SELL
$4.78 - $8.26 $287,756 - $497,252
-60,200 Reduced 72.79%
22,500 $31,000
Q1 2020

May 11, 2020

BUY
$4.0 - $21.53 $231,200 - $1.24 Million
57,800 Added 232.13%
82,700 $1,000
Q4 2019

Feb 11, 2020

BUY
$13.94 - $24.12 $347,106 - $600,588
24,900 New
24,900 $13,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.